Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
lung cancer
Apr 14, 2024, 13:02 |
Blog
Herbert Loong: A whirlwind trip to Taipei to attend TASLC co-organised Conversations In Oncology meeting
Herbert Loong, Clinical Associate Professor at The Chinese University of Hong Kong, shared a post on…
Apr 14, 2024, 12:05
OncoDaily Party 2024
OncoDaily Party 2024: Summer is Coming May 31, 2024: Registration from 7:30 PM to 8:30…
Apr 14, 2024, 06:47 |
Blog
Hagop Youssoufian: I'm very pleased to serve on the Clinical and Regulatory Advisory Board of AffyImmune Therapeutics
Hagop Youssoufian, Founder and Principal of Youssoufian Consulting, LLC, posted on LinkedIn: "I'm very pleased…
Apr 13, 2024, 11:26 |
Positive
Eric K. Singhi: An incredible privilege to join the IASLC Academy!
Eric K. Singhi, Thoracic/head and neck medical oncologist and Assistant Professor at the MD Anderson…
Apr 13, 2024, 09:40 |
Drugs
Rami Manochakian: Results of adjuvant Alectinib vs Chemotherapy in resected ALK+ stage IB-IIIA NSCLC
Rami Manochakian, thoracic medical oncologist at Mayo Clinic, shared a post on X: "Hot off…
Apr 13, 2024, 09:17 |
Societies
30 Posts Not To Miss From AACR24!
The AACR Annual Meeting 2024 was held from April 5th to 10th in San Diego,…
Apr 13, 2024, 08:37 |
Insight
New Paper Alert! How concurrent Medication Impacts The Outcomes Of Patients Treated with Immune Checkpoint Inhibitors
How concurrent Medication Impacts The Outcomes Of Patients Treated with Immune Checkpoint Inhibitors Published in…
Apr 12, 2024, 17:34 |
Blog
Narjust Florez: IASLC Members, share your insights by completing our DEI survey
Narjust Florez shared on X/Twitter: "IASLC Members, join our commitment to diversity, equity and inclusion…
Apr 12, 2024, 16:43 |
Drugs
Tanja Obradovic: Exciting new vaccine is about to start Phase III in advanced NSCLC patients that progressed following immunotherapy
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, recently shared on LinkedIn: “Exciting…
Apr 12, 2024, 12:47 |
Insight
Christine Lovly: Reflecting on AACR24
Christine Lovly shared on X/Twitter: "Reflecting on AACR24: - Phenomenal cancer science and medicine, -…
126
127
128
129
130
All:
1589
Posts:
1271 - 1280
CityU-AFCR Symposium on Precision Medicine and Digital Medicine
New management team at St. Anna Children's Hospital
Key Inspirational Moments with WHO Director at the Olympic Games
Remembering Susan Wojcicki, Honoring a Legacy of Leadership and Technological Innovation
MASCC24 Highlights: The Ideal Location for Care Varies According to Disease, Patient and Family Characteristics
Facebook
RSS Feed
Twitter
Linkedin
Youtube